Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Moderate to Severe Lichen Planus
NCT00285779Phase 2Terminated
- Sponsor
- Stanford University
- Start
- Aug 2006
- Primary completion
- Nov 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of etanercept in lichen planus (LP), sponsored by Stanford University. Started Aug 2006; status: terminated.
02
Drugs
etanercept
03
Conditions
lichen planus (LP)
Beyond the preview
Go deeper on NCT00285779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00285779.